Elevance Health targets at least $25.50 adjusted EPS for 2026 as company signals margin recovery and portfolio repositioning
2026-01-28 13:06:09 ET
More on Elevance Health
- Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
- Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain
- Elevance Health, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Elevance Health raises dividend by 0.6% to $1.72 a share
- Elevance Health is the latest health insurer to face 2026 revenue decline
Read the full article on Seeking Alpha
For further details see:
Elevance Health targets at least $25.50 adjusted EPS for 2026 as company signals margin recovery and portfolio repositioningNASDAQ: ELV
ELV Trading
1.62% G/L:
$291.77 Last:
829,361 Volume:
$291.32 Open:



